+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

From
From
Rifaximin Capsules Market - Global Forecast 2025-2030 - Product Thumbnail Image

Rifaximin Capsules Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
Rifaximin for Suspension Market - Global Forecast 2025-2030 - Product Thumbnail Image

Rifaximin for Suspension Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
From
From
From
Rifaximin Tablets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Rifaximin Tablets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
Chlordiazepoxide Tablets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Chlordiazepoxide Tablets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 180 Pages
  • Global
From
Antidiarrheal Microorganisms Market - Global Forecast 2025-2030 - Product Thumbnail Image

Antidiarrheal Microorganisms Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
Magnesium Oxide Nanoparticles - Global Strategic Business Report - Product Thumbnail Image

Magnesium Oxide Nanoparticles - Global Strategic Business Report

  • Report
  • January 2026
  • 141 Pages
  • Global
From
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more